SUTRO BIOPHARMA, INC. (STRO) › Net IncomeSUTRO BIOPHARMA, INC. (STRO) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: $1.70M2017: -$19.69M2018: -$35.32M2019: -$119.20M2020: -$32.13M2021: -$105.54M2022: -$119.20M2023: -$106.79M2024: -$227.46M2025: -$191.09M-$191.09M2016Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$191.09M+16.0%2024-$227.46M-113.0%2023-$106.79M+10.4%2022-$119.20M-12.9%2021-$105.54M-228.5%2020-$32.13M+73.0%2019-$119.20M-237.5%2018-$35.32M-79.4%2017-$19.69M-1256.8%2016$1.70M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share